002720 — Kukje Pharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual balance sheet for Kukje Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,273	7,903	5,559	10,632	8,755
Net Total Accounts Receivable
Net Total Receivables	23,937	23,486	20,359	22,141	24,656
Total Inventory
Prepaid Expenses
Total Current Assets	49,940	48,197	48,535	55,119	56,974
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	86,986	81,981	78,380	99,124	98,185
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	145,626	139,783	136,593	163,259	165,548
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	55,358	54,517	47,855	59,687	28,547
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	75,143	71,215	62,519	78,315	76,006
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	70,482	68,568	74,074	84,944	89,542
Total Liabilities & Shareholders' Equity	145,626	139,783	136,593	163,259	165,548
Total Common Shares Outstanding